SYSTEMIC AND LOCAL ANTITUMOR EFFECT OF THE ANTIBIOTIC SPIRAMYCIN: A PHARMACOLOGIC AND CLINICAL STUDY.
D000230:Adenocarcinoma; D000818:Animals; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D002286:Carcinoma, Ehrlich Tumor; D004285:Dogs; D007939:Leukemia L1210; D008228:Lymphoma, Non-Hodgkin; D008545:Melanoma; D051379:Mice; D009369:Neoplasms / Q000628:therapy*; D009374:Neoplasms, Experimental; D010600:Pharmacology; D051381:Rats; D012106:Research; D012510:Sarcoma 180; D012514:Sarcoma, Kaposi; D015572:Spiramycin; D046509:Tissue Culture Techniques
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D015572:Spiramycin
ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; DOGS; EXPERIMENTAL LAB STUDY; LEUKEMIA L1210; LYMPHOSARCOMA; MELANOMA; MICE; NEOPLASM THERAPY; NEOPLASMS, EXPERIMENTAL; PHARMACOLOGY; RATS; SARCOMA 180, CROCKER; SARCOMA, KAPOSI'S; SPIRAMYCIN; TISSUE CULTURE